Drug kills triple negative breast cancer cells
A newly identified drug kills triple negative breast cancer cells and stops the formation of blood vessels that tumors need to grow.
A newly identified drug kills triple negative breast cancer cells and stops the formation of blood vessels that tumors need to grow.
A newly identified drug kills triple negative breast cancer cells and stops the formation of blood vessels that tumors need to grow.
A newly identified drug kills triple negative breast cancer cells and stops the formation of blood vessels that tumors need to grow.
New research digs into the underlying factors that cause the harmful transformation of immune cells from good to bad.
New research identifies a potential new immune system target to head off the spread of breast cancer cells.
New research identifies a potential new immune system target to head off the spread of breast cancer cells.
“Our hope is that if early detection [of brain cancer] is more feasible, then there is an increased chance of survival.”
“With these newly developed computational models, we can now determine how cancer cells invade into breast tissue in three dimensions…”
Researchers have identified which immune cells drive cardiac inflammation in cancer patients taking doxorubicin, a common chemotherapy drug.
“We’re giving clinicians a more powerful tool that can find cancer cells earlier and more precisely than ever before.”